-

Asahi Kasei Medical Bioprocess Affiliate Opens in China

original Planova™ virus removal filters (Photo: Business Wire)

Planova™ virus removal filters (Photo: Business Wire)

SHANGHAI--(BUSINESS WIRE)--Asahi Kasei Medical announces that an affiliated company in China, Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC), started business on April 1, 2021.

Asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide “Assurance Beyond Expectation” to ensure product safety and manufacturing efficiency for therapeutics within the biopharmaceutical industry in the form of innovative yet exceptionally reliable purification consumables, equipment and support services.

The global COVID-19 pandemic has increased demand for Planova™ filters as pharmaceutical companies rapidly develop and mass-produce anti-coronavirus agents. Asahi Kasei Medical continues to reinforce its global supply infrastructure for Planova™ in order to support the early provision of coronavirus vaccines and therapies to as many people as possible.

The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times while enabling settlement denominated in Chinese yuan. AKBC will also provide deep technical advice and support as well as hands-on training to enable local customers to use the products with greater ease.

Asahi Kasei Medical contributes to life and living for people around the world as a member of the Asahi Kasei Group’s Health Care Sector, enabling biologics manufacturers to safely and efficiently produce medicines that patients can trust.

Corporate Profile of Asahi Kasei Bioprocess (Shanghai) Co., Ltd.

Location:

999 Huaihai Road, Huai Hai Lu Xi Duan, Xuhui District, Shanghai, China

President:

Weichao Zhu

Business content:

  • Import and sale of Planova™ virus removal filters and bioprocess related products and provision of related technical support
  • Provision of technical support related to bioprocess equipment

Establishment:

August 2020 (operation started in April 2021)

Shareholder:

Asahi Kasei (China) Co., Ltd. 100%

 

Contacts

For more information, please contact:
Ryo Kobayashi
Corporate Communications
Asahi Kasei Corp.
Phone: +81-(0)3-6699-3008

Industry:

Asahi Kasei Corp.

TOKYO:3407
Release Versions
EnglishChinese Simplified

Contacts

For more information, please contact:
Ryo Kobayashi
Corporate Communications
Asahi Kasei Corp.
Phone: +81-(0)3-6699-3008

More News From Asahi Kasei Corp.

Asahi Kasei Successfully Demonstrates Biomethane Production with High Yield and High Purity Using Biogas from Organic Waste

TOKYO & NOVI, Mich. & DÜSSELDORF, Germany--(BUSINESS WIRE)--Diversified global manufacturer Asahi Kasei has successfully completed a demonstration trial of an innovative biogas purification system using zeolites in Kurashiki, Okayama Prefecture, Japan. Begun in February 2025, the trial achieved biomethane production with yield of up to 99.5% or more and purity of 97% or more. With such exceptional performance in both yield and purity, the system holds promise for the cost-effective production a...

Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company

TOKYO & NEW YORK & DÜSSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei Corp. (TOKYO:3407) today announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei (“the Acquisition”) through a voluntary tender offer for Calliditas (“the Tender Offer”). The Tender Offer will also include a concurrent offer by Asahi Kasei to acquire all American Depos...

Dr. Akira Yoshino Chosen for the Grand Prize of the VinFuture Prize

TOKYO & HANOI, Vietnam--(BUSINESS WIRE)--Asahi Kasei Honorary Fellow Dr. Akira Yoshino has been chosen for the Grand Prize of the 2023 VinFuture Prize in recognition of his contributions to the invention of lithium-ion battery (LIB). Dr. Yoshino invented a completely new combination of carbon for the negative electrode and LiCoO2 (lithium cobalt oxide) for the positive electrode, developed the fundamental technology for the LIB which uses aluminum as positive current collector material, and fab...
Back to Newsroom